Every stroke is different
Heart disease has taken a toll on both my mother’s and my father’s sides of the family. However, I would never have imagined the direct and personal assault it would have on me or my immediate family until this past fall.
For weeks, my mother prayed the rosary on the phone with her sister, who was dying of colorectal cancer. Their conversations were carried out each morning over a period of hours, with a very slow cadence. After my aunt died, I thought nothing of my mother’s slower speech pattern. That was until she started to pass out and have muscle weakness.
One day, while I was at school at the university, my father had to take her to the emergency room of our local hospital. I was two bites into a cheeseburger when he called me.
“Connor, we’re not sure what’s going on so try not to be worried, but I’m at the hospital with mom and they think she may have had a ,” he said. I completely lost my appetite.
She’s only 65, I thought. She eats so many fruits and vegetables, I insisted. How could this be?
She stayed in the hospital overnight, while doctors conducted a variety of tests to gauge what exactly happened. After about a week, we learned that they believed she’d had a transient ischemic attack (kind of a ministroke), where a clot in the blood supply to the brain is only temporary. After her discharge, an internist determined that she has hypercholesteremia (a factor that likely has contributed).
My mother is now seeing a neurologist, and the situation may be more complex than what was originally hypothesized by physicians. She has changed her diet, has been put on statins, and is trying to exercise daily.
She is quick to brush away the notion that she has ever had a stroke, but, in the back of my mind, the thought is always there. So now, it is imperative that I am not only more aware but more prepared.
What to look for
Heart disease has continued to be a great public health burden not only in the Western world but globally, with millions passing away every year from coronary artery disease and strokes taking the majority of lives in both developed and underdeveloped countries.
May is National Stroke Awareness Month and is a great opportunity to become more aware and possibly save a life.
Many if not all of you are familiar with the acronym, but what does it actually mean? Facial drooping, arm weakness, speech difficulty and time (time to call emergency services).
Despite this simple acronym, there are other symptoms of an impending or occurring stroke that may alter on a case-by-case basis. The that a sudden and severe headache, dizziness or imbalance as well as confusion can also indicate a stroke in progress.
But take note: Not all strokes are the same. A stroke can be broadly characterized into two distinct categories: ischemic, where there is a block in a blood vessel supplying blood to the brain, and hemorrhagic, where there is bleeding into or around the brain. The rates of ischemic stroke are .
Since the brain controls the functions of the rest of the body, the effects of a stroke can often be systemic. To gain a broader understanding of a stroke, check out these from the .
Become a stroke hero by recognizing these signs, and check out some of the novel research being conducted below to advance our understanding of various aspects of cerebrovascular pathology.
Recent research
Exploring the relationship between stroke severity and glycocalyx dysfunction: Researchers working in multiple labs across Japan hoped to better understand the degradation of the endothelial of the blood–brain barrier after ischemic stroke. Most if not all cells in the human body are covered in the glycocalyx, a sugary coating of various polysaccharides linked to proteins with phenomenal diversity. Although the glycocalyx serves many different roles — including cellular recognition, signaling and structural stability — this study focused on its protective role of the cells that guard the blood–brain barrier. The team showed that in the hyperacute phase after a stroke (within a few hours of onset) there is a dramatic decrease in the levels of chondroitin sulfate and heparan sulfate glycosaminoglycans in brain tissue, while there is an increase in the expression of enzymes that digest these polymers. The researchers also identified a modified form of a precursor enzyme targeting heparan sulfate, which they suggested is a promising target for protecting stroke victims from subsequent inflammation in the brain.
Chatty fats: lipid signaling in the atherosclerotic state and implications for cerebrovascular events: A translational research team from labs in the Netherlands and China wanted to take a closer look at the role lipids play in the development and progression of atherosclerosis. While atherosclerosis in general refers to the buildup of plaque, fats and cholesterol in the artery walls, the location of plaque makes a big difference. When this buildup occurs somewhere between the heart and the brain, such as in the carotid artery, it can pose a serious risk for a cerebrovascular event, such as a stroke. Using highly sensitive analytical methods (), the researchers characterized and identified unique lipid profiles in human atherosclerotic plaques in the largest atherosclerotic dataset to date. They found there was a clear association of plaque development with specific lipid classes in these samples and potentially identified biomarkers using these lipids to identify high-risk patients.
X marks the spot: Identification of potential biomarkers and complex signaling networks in ischemic stroke: It is incredibly important for clinicians to have the most useful indicators of stroke for diagnosis, prognosis and subsequent treatment. Yet, there is still a great deal of work to be done to understand the molecular features of the complex state of a stroke. A team of researchers from Spain set out to integrate a large set of proteomic and transcriptomic data to unravel the molecular interactions and signaling secrets of the acute phase of a stroke. They performed extensive analysis of brain and blood samples from mice as well as humans exhibiting stroke-mimicking symptoms. They found differential expression of many genes and proteins after stroke onset, with two genes in particular potentially being useful as indicators for stroke diagnosis and prognosis.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.